BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 12904571)

  • 1. Repression of Smad transcriptional activity by PIASy, an inhibitor of activated STAT.
    Long J; Matsuura I; He D; Wang G; Shuai K; Liu F
    Proc Natl Acad Sci U S A; 2003 Aug; 100(17):9791-6. PubMed ID: 12904571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of Smad transcriptional activity by protein inhibitor of activated STAT3 (PIAS3).
    Long J; Wang G; Matsuura I; He D; Liu F
    Proc Natl Acad Sci U S A; 2004 Jan; 101(1):99-104. PubMed ID: 14691252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of transforming growth factor-beta signaling by protein inhibitor of activated STAT, PIASy through Smad3.
    Imoto S; Sugiyama K; Muromoto R; Sato N; Yamamoto T; Matsuda T
    J Biol Chem; 2003 Sep; 278(36):34253-8. PubMed ID: 12815042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sumoylation of Smad4, the common Smad mediator of transforming growth factor-beta family signaling.
    Lee PS; Chang C; Liu D; Derynck R
    J Biol Chem; 2003 Jul; 278(30):27853-63. PubMed ID: 12740389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor suppressor Smad4 is a transforming growth factor beta-inducible DNA binding protein.
    Yingling JM; Datto MB; Wong C; Frederick JP; Liberati NT; Wang XF
    Mol Cell Biol; 1997 Dec; 17(12):7019-28. PubMed ID: 9372933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear factor YY1 inhibits transforming growth factor beta- and bone morphogenetic protein-induced cell differentiation.
    Kurisaki K; Kurisaki A; Valcourt U; Terentiev AA; Pardali K; Ten Dijke P; Heldin CH; Ericsson J; Moustakas A
    Mol Cell Biol; 2003 Jul; 23(13):4494-510. PubMed ID: 12808092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The RING domain of PIASy is involved in the suppression of bone morphogenetic protein-signaling pathway.
    Imoto S; Sugiyama K; Yamamoto T; Matsuda T
    Biochem Biophys Res Commun; 2004 Jun; 319(1):275-82. PubMed ID: 15158472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The transcriptional co-activator P/CAF potentiates TGF-beta/Smad signaling.
    Itoh S; Ericsson J; Nishikawa J; Heldin CH; ten Dijke P
    Nucleic Acids Res; 2000 Nov; 28(21):4291-8. PubMed ID: 11058129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel E1A-like inhibitor of differentiation (EID) family member, EID-2, suppresses transforming growth factor (TGF)-beta signaling by blocking TGF-beta-induced formation of Smad3-Smad4 complexes.
    Lee HJ; Lee JK; Miyake S; Kim SJ
    J Biol Chem; 2004 Jan; 279(4):2666-72. PubMed ID: 14612439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Smad4/DPC4 and Smad3 mediate transforming growth factor-beta (TGF-beta) signaling through direct binding to a novel TGF-beta-responsive element in the human plasminogen activator inhibitor-1 promoter.
    Song CZ; Siok TE; Gelehrter TD
    J Biol Chem; 1998 Nov; 273(45):29287-90. PubMed ID: 9792626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Smad proteins and transcription factor Sp1 in p21(Waf1/Cip1) regulation by transforming growth factor-beta.
    Pardali K; Kurisaki A; Morén A; ten Dijke P; Kardassis D; Moustakas A
    J Biol Chem; 2000 Sep; 275(38):29244-56. PubMed ID: 10878024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of smad3 with a proximal smad-binding element of the human alpha2(I) procollagen gene promoter required for transcriptional activation by TGF-beta.
    Chen SJ; Yuan W; Lo S; Trojanowska M; Varga J
    J Cell Physiol; 2000 Jun; 183(3):381-92. PubMed ID: 10797313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TLP, a novel modulator of TGF-beta signaling, has opposite effects on Smad2- and Smad3-dependent signaling.
    Felici A; Wurthner JU; Parks WT; Giam LR; Reiss M; Karpova TS; McNally JG; Roberts AB
    EMBO J; 2003 Sep; 22(17):4465-77. PubMed ID: 12941698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transforming growth factor-beta repression of matrix metalloproteinase-1 in dermal fibroblasts involves Smad3.
    Yuan W; Varga J
    J Biol Chem; 2001 Oct; 276(42):38502-10. PubMed ID: 11502752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cooperative binding of Smad proteins to two adjacent DNA elements in the plasminogen activator inhibitor-1 promoter mediates transforming growth factor beta-induced smad-dependent transcriptional activation.
    Stroschein SL; Wang W; Luo K
    J Biol Chem; 1999 Apr; 274(14):9431-41. PubMed ID: 10092624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CHIP mediates degradation of Smad proteins and potentially regulates Smad-induced transcription.
    Li L; Xin H; Xu X; Huang M; Zhang X; Chen Y; Zhang S; Fu XY; Chang Z
    Mol Cell Biol; 2004 Jan; 24(2):856-64. PubMed ID: 14701756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The tumor suppressor Smad4/DPC 4 as a central mediator of Smad function.
    Zhang Y; Musci T; Derynck R
    Curr Biol; 1997 Apr; 7(4):270-6. PubMed ID: 9094310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Smad2, Smad3 and Smad4 cooperate with Sp1 to induce p15(Ink4B) transcription in response to TGF-beta.
    Feng XH; Lin X; Derynck R
    EMBO J; 2000 Oct; 19(19):5178-93. PubMed ID: 11013220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct binding of Smad3 and Smad4 to critical TGF beta-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene.
    Dennler S; Itoh S; Vivien D; ten Dijke P; Huet S; Gauthier JM
    EMBO J; 1998 Jun; 17(11):3091-100. PubMed ID: 9606191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A putative protein inhibitor of activated STAT (PIASy) interacts with p53 and inhibits p53-mediated transactivation but not apoptosis.
    Nelson V; Davis GE; Maxwell SA
    Apoptosis; 2001 Jun; 6(3):221-34. PubMed ID: 11388671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.